The IOI Synergy Grants scheme is an internal Oxford-wide funding call for AMR-focused research with translational potential and with a strong focus on collaboration across university departments and disciplines.
Each project will receive funding of up to £500,000 over a two-year period. Projects include new antibiotic drug discovery, development of diagnostic tools to accurately diagnose infections, phages to kill drug-resistant bacteria, and behavior change interventions to reduce antibiotic usage.
Professor Sir Stewart Cole, Executive Chair of the IOI:
“AMR is a multi-faceted problem that cannot be solved by working in silos. Experts from medical sciences, life sciences and social sciences must work in unison to protect the existing antibiotics and find new ones. The IOI Synergy Grants bring together Oxford’s world-class researchers in an integrated multidisciplinary approach to shape the future of modern medicine.
The projects exemplify the tremendous range of AMR research across the university, from new diagnostic tools to patient-facing interventions. The quality of research is outstanding, and I look forward to seeing real-world applications arise from the IOI Synergy initiative.”
Read the full story on the Ineos Oxford Institute website.
more recommended stories
36-Week Pre-eclampsia Screening May Reduce Term RiskA New Preventive Strategy for Term.
Cardiovascular Risk and Sudden Cardiac Death in DiabetesRising Sudden Cardiac Death (SCD) Risk.
Poor Kidney Function and Alzheimer’s Biomarkers ExplainedPoor kidney function may influence levels.
Walking Speed Before Hip Replacement Predicts RecoveryNew Evidence Points to a Simple,.
Neuroblastoma Drug Combo Extends Survival in ModelsA Promising Shift in High-Risk Neuroblastoma.
How Soybean Oil Impacts Weight Gain and MetabolismWhy Soybean Oil May Affect Metabolism.
Coffee and Cognitive Function: Evidence ReviewA new narrative review in Cureus.
Colorectal Cancer Screening Rates Low in Adults 45–49Recent UCLA research reveals that colorectal.
Gut Immune Cells and Long-Lasting Antiviral Protection.Breakthrough Findings on How Gut Immune.
Mild Pancreatic Duct Dilatation Signals Higher Cancer RiskEarly Structural Changes Offer Critical Clues.
Leave a Comment